Regulatory Blog

Developing a new drug is a long, expensive, and complex process. To make drug development more efficient and scientifically robust, the U.S. Food and Drug Administration (FDA) encourages the use of Drug Development Tools (DDTs) . These tools help sponsors generate better data, make informed decisions, and reduce uncertainty during drug development. To support this, FDA has established formal Drug Development Tool Qualification Programs, described on the FDA website Drug Deve